久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Sanofi's novel drug for teen skin disease OK'd in China

By Zhou Wenting in Shanghai | chinadaily.com.cn | Updated: 2021-09-15 13:38
Share
Share - WeChat
The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020. [Photo/Agencies]

An innovative targeted biological agent developed by French pharmaceutical company Sanofi was recently approved by the National Medical Products Administration to treat moderate to severe atopic dermatitis in teenagers aged 12 and above.

The company said on World AD Day on Tuesday that the drug, which was approved in China on Sept 9, aimed to help young patients relieve physical and psychological burdens.

AD is a common immunoinflammatory disease that seriously affects the health and quality of life of millions of sufferers in the country. The disease is characterized by chronic and recurrent itching and skin injuries. Many patients suffer from lasting sleeping problems and depression.

A report published last year by the China Association of Health Promotion and Education and Sanofi China showed that more than half of AD patients were below 20 when they were first diagnosed.

Guo Yifeng, deputy director of the dermatological department of Xinhua Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, said that a key negative impact brought by the disease to adolescent sufferers is that it affects their appearance and makes them less confident in socializing.

"We've encountered many teenage patients who often avoid socializing with peers and some who even suffer from depression," she said.

Doctors said that the injection avoids widespread suppression of people's immune system and is thus expected to bring revolutionary changes to the treatment of the disease.

The incidence of the disease has been rising in China, owing to a Westernized lifestyle, urbanization and industrialization, experts said.

Epidemiological investigation results showed that the incidence of AD rose from around 3 percent in 2004 to nearly 13 percent in 2014.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 日韩免费高清一级毛片 | 亚洲欧美日韩综合二区三区 | 天天夜天干天天爽 | 亚洲欧洲国产成人综合一本 | 欧美成人精品欧美一级乱黄 | 欧美成人免费观看久久 | 欧美一级做 | 亚洲成人aa | 亚洲深夜福利视频 | www.黄色免费网站 | 国产成人cao在线 | 日韩欧美特级毛片 | 国产不卡毛片 | 国产精品高清视亚洲一区二区 | 免费视频99 | 一级做a爰全过程免费视频毛片 | 最近手机中文在线视频 | 免费视频亚洲 | 一级做a爰性色毛片 | 天海翼精品久久中文字幕 | 欧美在线播放成人免费 | 国产乱纶 | 国产三级成人 | 91av小视频 | a毛片视频| 欧美高清另类自拍视频在线看 | 亚洲国产成人99精品激情在线 | 最新中文字幕一区二区乱码 | 狠狠色丁香婷婷久久综合不卡 | 欧美人成片免费看视频不卡 | 男女视频在线观看免费高清观看 | 精品视频免费在线 | 免费观看欧美成人禁片 | 亚洲欧美一区二区三区综合 | 精品国产午夜久久久久九九 | 高清成人爽a毛片免费网站 高清大学生毛片一级 | 99久久精品免费看国产一区二区三区 | 欧美一区三区 | 亚洲激情 欧美 | 欧美a在线播放 | 精品久久网站 |